The IRONMAN trial investigates the safety and effectiveness of intravenous iron treatment in heart failure patients. Although the primary outcomes did not reach statistical significance, further analysis suggests a potential impact on heart failure hospitalizations and cardiac death. These findings contribute to the growing evidence supporting iron deficiency assessment and treatment in heart failure patients.